Skip to main content

Animations

MJFF Publications

3831 - 3840 of 8673 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • 2023
  • 2023
  • 2022
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18443
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up study
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18538
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Subsensory stochastic electrical stimulation targeting muscle afferents alters gait control during locomotor adaptations to haptic perturbations
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.107038
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xgen.2023.100316
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Unaltered T cell responses to common antigens in individuals with Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jns.2022.120510
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Golgi-IP, a tool for multimodal analysis of Golgi molecular content
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2219953120
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Ageing-associated small RNA cargo of extracellular vesicles
    Journal Name: RNA Biology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15476286.2023.2234713
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Structural and biochemical insights into lipid transport by VPS13 proteins
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202202030
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Parallel neurodegenerative phenotypes in sporadic Parkinson’s disease fibroblasts and midbrain dopamine neurons
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102501
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41592-023-01993-x
    Citation Count: 92
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.